Pages
Products
AAV9-αMHC-GFP

AAV9-αMHC-GFP

Cat.No. :  AAV00265Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 9 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00265Z
Description AAV serotype 9 particles contain GFP under the mouse alpha myosin heavy chain (αMHC) promoter for specific expression in cardiac muscle cells.
Reporter GFP
Serotype AAV Serotype 9
Application

1. Determination of optimal MOI (multiplicity of infection), administration methods etc.

2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue.

3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery.

Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

Over the past decade, adeno-associated virus (AAV) vectors have received increasing attention in basic, preclinical, and clinical research, and AAV vectors are now one of the most promising vector systems for gene therapy applications. This is partly because AAV is not associated with any known human disease, AAV vectors can produce long-term transgene expression at least in non-dividing cells (even in the absence of genomic integration), and AAV exhibits relatively low immunogenicity. The AAV 4.6 kb single-stranded DNA genome contains two viral genes: rep and cap. These genes can be removed and replaced with a cassette that expresses a therapeutic transgene, along with the necessary rep and cap genes. The cap gene encodes three proteins, VP1, VP2, and VP3, of which 60 VP monomers make up the complete icosahedral AAV capsid, with a VP1:VP2:VP3 ratio of 1:1:10. The VP1 and VP2 proteins each contain the complete VP3 amino acid sequence, which constitutes the structure of the capsid. Unique regions of VP1 and VP2 perform additional functions, such as endosomal escape. VP3 contains nine flexible loops called hypervariable regions (HVRs) that account for the majority of sequence and structural variation among AAV serotypes, which are organized into larger groups called clades based on shared sequences. These variations confer unique properties to these serotypes, such as receptor binding, tissue tropism, and antigenicity.

Voltage-dependent anion channel 2 (VDAC2) is a mitochondrial outer membrane porin known to play an important role in apoptosis and calcium signaling. To elucidate the role of VDAC2 in calcium homeostasis, researchers generated a ventricular myocyte-specific developmental deletion of Vdac2 in mice. These results show that the loss of VDAC2 in the myocardium leads to a severe impairment of excitation-contraction coupling by altering intracellular and mitochondrial calcium signaling. Researchers also observed adverse cardiac remodeling that progressed to severe cardiomyopathy and death. Reintroduction of VDAC2 in 6-week-old knockout mice partially rescued the cardiomyopathy phenotype. In a mouse model of pressure overload-induced heart failure, activation of VDAC2 by efsevin increased cardiac contractility. Together, these results suggest that VDAC2 plays a critical role in cardiac function by affecting cellular calcium signaling.

Here, researchers evaluated the cardiac ventricular myocyte-specific reintroduction of VDAC2 in KO and WT mice using western blotting and qRT-PCR (Figure 1a, b). Serial echocardiography was performed in these mice until 10 weeks after injection (16-week-old mice) to obtain comparable results. Compared with KO mice injected with the control AAV9-αMHC-GFP vector, KO mice injected with the AAV9-αMHC-VDAC2-GFP vector showed relative improvement in EF, FS, and LV volume, and a decrease in LV diameter, and improved cardiac structure and function were observed (Figure 1c-g). Complete restoration of the phenotype was not observed, however, reintroduction of VDAC2 contributed to improved cardiac function.

Partial rescue of HF phenotype upon VDAC2 reintroduction.Figure 1. Partial rescue of HF phenotype upon VDAC2 reintroduction. (Shankar T S, et al., 2021)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Reproducible Results

Across multiple experiments, we observed reproducible results with high GFP expression levels in cardiac cells. This consistency makes it an invaluable tool for any cardiac research project focused on gene expression analysis.

French

07/25/2023

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction